Cardiovascular Disease
New tools help rheumatologists take on CVD risk management
New and emerging risk stratification tools can assist rheumatologists who are increasingly “taking on the challenge” of cardiovascular risk management in patients, according to a speaker at the 2020 Congress of Clinical Rheumatology-East.
Cardiac outpatients commonly have psychiatric disorders
Top in cardiology: Menopause and CVD, aspirin bleeding risk
According to a presentation at the virtual Heart in Diabetes Conference, physicians should discuss CVD risk reduction by the time a woman hits menopause.
LoDoCo2: Low-dose colchicine reduces CV events by 31% on top of optimal medical therapy
In patients with chronic coronary disease, adding low-dose colchicine to optimal medical therapy reduced risk for CV events by 31%, according to results of the LoDoCo2 trial presented at the European Society of Cardiology Congress.
High BPA exposure may increase all-cause mortality
Exposure to the endocrine-disrupting chemical bisphenol A was significantly and positively associated with all-cause mortality in U.S. adults, according to an analysis of National Health and Nutrition Examination Survey data.
Women with HIV face higher burden of hypertension, other health conditions
Women with HIV have a higher burden of hypertension, diabetes, lung disease and cardiovascular disease than HIV-negative women, according to data published in Clinical Infectious Diseases.
Multidisciplinary NAFLD approach improves liver-related, cardiovascular risk factors
Triple combination therapy may be optimal for CV protection in type 2 diabetes
Triple therapy combining an SGLT2 inhibitor, a GLP-1 receptor agonist and the thiazolidinedione pioglitazone could serve as an optimal solution for cardiovascular and renal protection in type 2 diabetes, according to a speaker.
Food insecurity tied to increased risk for mortality in US adults
People who experience food insecurity in the United States may be more likely to experience all-cause and cardiovascular mortality, according to a study published in Health Promotion Practice.
‘It’s never too late’: Tailoring glucose management in advanced CKD
Glucose management remains important for adults with diabetes and advanced chronic kidney disease as a strategy to prevent or delay progression to dialysis, prevent cardiovascular events and improve quality of life, according to a speaker.